Hollander, E. E., Desai, A. S., Marshall, A., Shipman, K., Martins, R., Sarmiento, N., Dengel, L., O'Neill, M., Bevenour, K., Kotch, A., Plesa, G., Brennan, A., Leskowitz, R. M., Hexner, E. O., Hwang, W., Siegel, D. L., June, C. H., Binder, Z. A., O'Rourke, D., Bagley, S. (2026). Updated overall survival, safety, and neurologic function outcomes from a phase 1 trial of bivalent chimeric antigen receptor (CAR) T cell therapy in recurrent glioblastoma (GBM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2013